LIDOCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lidocaine, and when can generic versions of Lidocaine launch?
Lidocaine is a drug marketed by Ailex Pharms Llc, Alembic, Alkem Labs Ltd, Amneal Pharms, Belmora Llc, Cosette, Dr Reddys, Encube, Fougera Pharms Inc, Glenmark Pharms Ltd, Macleods Pharms Ltd, Quagen, Rising, Septodont Inc, Strides Pharma, Taro, Teva Pharms Usa, Vitruvias Therap, Actavis Labs Ut Inc, Amneal, Ibsa, Mylan Technologies, Nal Pharm, Noven Pharms Inc, Fougera Pharms, Hikma, Padagis Us, Pai Holdings Pharm, Rhodes Pharms, Abbott, Abraxis Pharm, Afaxys, Am Regent, Aspiro, B Braun Medical Inc, Bel Mar, Dell Labs, Elkins Sinn, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Huons, Intl Medication, Luitpold, Lyphomed, Mankind Pharma, Miles, Sintetica Us, Spectra Mdcl Devices, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Sentiss, Watson Labs Inc, Rubicon, Wockhardt Bio Ag, Lannett Co Inc, Novitium Pharma, Paco, Baxter Hlthcare, B Braun, Eastman Kodak, Empi, Mylan Labs Ltd, Actavis Mid Atlantic, and Chartwell Molecular. and is included in one hundred and forty NDAs.
The generic ingredient in LIDOCAINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for LIDOCAINE
US Patents: | 0 |
Applicants: | 68 |
NDAs: | 140 |
Finished Product Suppliers / Packagers: | 39 |
Raw Ingredient (Bulk) Api Vendors: | 131 |
Clinical Trials: | 1,780 |
Patent Applications: | 5,622 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LIDOCAINE |
Drug Sales Revenues: | Drug sales revenues for LIDOCAINE |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for LIDOCAINE |
What excipients (inactive ingredients) are in LIDOCAINE? | LIDOCAINE excipients list |
DailyMed Link: | LIDOCAINE at DailyMed |
Recent Clinical Trials for LIDOCAINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Arkansas Children's Hospital Research Institute | Phase 4 |
Universitas Sebelas Maret | Phase 4 |
Indonesia Endowment Fund for Education | Phase 4 |
Pharmacology for LIDOCAINE
Drug Class | Amide Local Anesthetic Antiarrhythmic |
Physiological Effect | Local Anesthesia |
Medical Subject Heading (MeSH) Categories for LIDOCAINE
Anatomical Therapeutic Chemical (ATC) Classes for LIDOCAINE
US Patents and Regulatory Information for LIDOCAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 083158-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Sintetica Us | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 214269-001 | May 5, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Abraxis Pharm | LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 017508-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |